Clinical Trials Browser

Completed × birtamimab × Plasma cell × Clear all

NCT02632786 2019-04-05

PRONTO

Phase 2 Completed

129 enrolled 18 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Paraproteinemias

NCT01707264 2018-08-28

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Phase 1/2 Completed

Immunoglobulin Light-chain Amyloidosis